Gout Journal Articles

• Improvements With Pegloticase Plus MTX in Uncontrolled Gout Learn more about the benefits of pegloticase used in combination with methotrexate for the treatment of uncontrolled gout.
  Arthritis Research & Therapy, January 31, 2023
• Colchicine Use and the Risk of CKD Progression A new study examined the effects of colchicine treatment among patients with CKD. What have we learned?
  Rheumatology, December 13, 2022
• How Do I Diagnose Maturity Onset Diabetes of the Young? A better understanding and increased awareness of this rare form of diabetes could lead to earlier diagnosis and improved clinical care for these patients.
  Clinical Endocrinology, November 03, 2022
• Serum Uric Acid Lowering With Empagliflozin in HFrEF Lowering of serum uric acid may be an added benefit of SGLT-2 inhibitors. Might it improve outcomes in patients with heart failure with reduced ejection fraction?
  European Heart Journal, October 26, 2022
• Amniotic Membrane and Umbilical Cord for Pressure Injuries This product, used as an injectable particulate, could provide an effective treatment option for chronic pressure injuries.
  Wounds, October 24, 2022
• MTX to Increase Response in Gout Receiving Pegloticase Might the addition of methotrexate help increase pegloticase treatment response in patients with uncontrolled gout?
  Arthritis Research & Therapy, October 11, 2022
• The Dawn of a New Era of Targeted Lipid-Lowering Therapies Recent advancements have provided new targets and novel therapies for lipid management.
  European Heart Journal, October 10, 2022
• Chronic Pain in the 11th Revision of the ICD This article presents answers to frequently asked questions regarding the new, more comprehensive ICD-11 chronic pain classification, and its application to common pain syndromes.
  Pain, September 27, 2022
• En Masse Excision and Curettage for Gouty Tophi of the Hands Patients who underwent this surgical intervention realized decreased pain and functional improvements with limited complications.
  ePlasty, September 15, 2022
• Verinurad and Allopurinol in CKD Patients With Hyperuricemia Learn more about the treatment effects of this combination therapy in patients with CKD and hyperuricemia.
  Nephrology Dialysis Transplantation, September 05, 2022
• Cannabidiol for Hand Osteoarthritis and Psoriatic Arthritis This study found no significant benefit of cannabidiol over placebo for pain intensity in patients with hand osteoarthritis and psoriatic arthritis.
  Pain, July 07, 2022
• Gout Flares After Treat-to-Target and Tight-Control Therapy How frequent are gout flares during the first and second year of a treat-to-target strategy?
  Arthritis Research & Therapy, June 07, 2022
• Acute Kidney Injury is Linked to Neurocognitive Impairments A new study finds that an episode of acute kidney injury could have negative impacts on neurocognitive functioning.
  Nephrology Dialysis Transplantation, May 04, 2022
• Prevalence of Arthritis and Disparities in Social Risk Factors This study examined the prevalence of arthritis and its associated burden according to social risk factors, as well as the impact of co-occurring social risks on arthritis.
  Preventing Chronic Disease, April 15, 2022
• A Pilot Study of Cognition Among Hypoparathyroid Adults A new study aims to provide insights into the possible association between hypoparathyroidism and cognitive impairments.
  Journal of the Endocrine Society, March 29, 2022
• Colchicine in Cardiovascular Disease: In-Depth Review Colchicine is a safe and well-tolerated anti-inflammatory agent. Explore its mechanisms of action and potential utility in cardiovascular disease in this paper.
  Circulation, February 28, 2022
• Update on Gout Management: What Is Old and What Is New Get up-to-date on the most recent advances in the management of gout.
  Current Opinion in Rheumatology, February 16, 2022
• Counseling for Physical Activity for Adults With Arthritis This study indicates that self-management class attendance and health care provider counseling for physical activity varies by state and sociodemographic characteristics among adults with arthritis.
  Morbidity & Mortality Weekly Report, January 07, 2022
• Surgical Reconstruction of Tophaceous Gout in the Hand In this article, the authors describe a customized approach to surgical reconstruction in a patient with severe gout in both hands.
  Plastic Reconstructive Surgery-Global Open (PRS Global Open), December 14, 2021
• Immune Checkpoint Inhibitor Treatment Toxicity Risk in RA A new analysis investigates the potential for patients with rheumatoid arthritis to experience adverse events after treatment with immune checkpoint inhibitors.
  Journal of Clinical Rheumatology, November 01, 2021